GeneDx Holdings Company Insiders
| WGS Stock | 104.39 7.68 7.94% |
GeneDx Holdings employs about 1000 people. The company is managed by 20 executives with a total tenure of roughly 2334 years, averaging almost 116.0 years of service per executive, having 50.0 employees per reported executive. Breaking down GeneDx Holdings' management performance can provide insight into the firm performance.
GeneDx |
GeneDx Holdings Management Team Effectiveness
The company has Return on Asset of (0.032) % which means that on every $100 spent on assets, it lost $0.032. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.221) %, meaning that it generated no profit with money invested by stockholders. GeneDx Holdings' management efficiency ratios could be used to measure how well GeneDx Holdings manages its routine affairs as well as how well it operates its assets and liabilities.GeneDx Holdings Workforce Comparison
GeneDx Holdings Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 28,147. GeneDx Holdings holds roughly 1,000 in number of employees claiming about 4% of equities under Health Care industry.
The company has Net Profit Margin of (0.17) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.11 %, which entails that for every 100 dollars of revenue, it generated $0.11 of operating income. GeneDx Holdings Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GeneDx Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on GeneDx Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, GeneDx Holdings insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GeneDx Holdings Notable Stakeholders
A GeneDx Holdings stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GeneDx Holdings often face trade-offs trying to please all of them. GeneDx Holdings' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GeneDx Holdings' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Katherine Stueland | CEO President | Profile | |
| Daniel JD | Secretary | Profile | |
| Heidi JD | Chief Officer | Profile | |
| Britt Johnson | Head Affairs | Profile | |
| Jami Biliboaca | Head Strategy | Profile | |
| Eric Olivares | Chief Officer | Profile | |
| Tricia Truehart | Head Relations | Profile | |
| MBA JD | General Counsel | Profile | |
| Bryan Dechairo | Chief Officer | Profile | |
| FACMG MD | Chief Officer | Profile | |
| Sabrina Dunbar | Chief Staff | Profile | |
| Jerry Conway | Senior Access | Profile | |
| Kevin Feeley | Chief Officer | Profile | |
| Paul MD | Chief Officer | Profile | |
| Melanie Duquette | Chief Officer | Profile | |
| Jennifer Brendel | Chief Affairs | Profile | |
| Feras Hantash | Senior Oncology | Profile | |
| Kevin CPA | Chief Officer | Profile | |
| Jason Ryan | Executive Board | Profile | |
| Karen Ponchner | Senior Operations | Profile |
About GeneDx Holdings Management Performance
The success or failure of an entity such as GeneDx Holdings Corp often depends on how effective the management is. GeneDx Holdings management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GeneDx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GeneDx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in GeneDx Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GeneDx Holdings Corp. Check GeneDx Holdings' Beneish M Score to see the likelihood of GeneDx Holdings' management manipulating its earnings.
GeneDx Holdings Workforce Analysis
Traditionally, organizations such as GeneDx Holdings use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare GeneDx Holdings within its industry.GeneDx Holdings Manpower Efficiency
Return on GeneDx Holdings Manpower
| Revenue Per Employee | 305.4K | |
| Revenue Per Executive | 15.3M | |
| Net Loss Per Employee | 52.3K | |
| Net Loss Per Executive | 2.6M | |
| Working Capital Per Employee | 143.2K | |
| Working Capital Per Executive | 7.2M |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.